AUTHORS
Qiongdi Zhang, Wenhuo Hu2, Joshua Theriot, MS3, Michael Lee Lee, BS4, Sabrina Rinaldi5, Sisi Zheng, MD6
AFFILIATIONS
1 UT Southwestern Medical Center, Dallas, Texas, United States
2 Saint Jude Children's Hospital, Memphis, Tennessee, United States
3 UT Southwestern Medical Center, Dallas, Texas, United States
4 UT Southwestern Medical Center, Dallas, Texas, United States
5 UT Southwestern Medical Center, Dallas, Texas, United States
6 UT Southwestern Medical Center, Dallas, Texas, United States
ABSTRACT
Type I interferons (IFN-I) are essential mediators of host defense and stress hematopoiesis, yet persistent IFN-I activity may impose a substantial cost on normal hematopoietic stem cells (HSCs). Whether this cost contributes to clonal hematopoiesis (CH) by directly enhancing mutant HSC fitness or by weakening their wild-type (WT) competitors remains unclear. Here, we investigated how chronic IFN-I activity shapes competition between WT and Dnmt3aR878H/+ HSCs.
We previously demonstrated that loss of the chromatin reader Mpp8 induces a retrotransposon-mediated IFN-I response within the bone marrow (BM) microenvironment that promotes the competitive advantage of clonally mutated HSCs through a cell-extrinsic inflammatory mechanism. To do this, we performed competitive transplantation studies in which Vav-iCre;Dnmt3aR878H/+ and WT whole BM cells were mixed at a 1:5 ratio and transplanted into either Mpp8-sufficient or Mpp8-deficient recipient mice (n=6-8 per group). In terminal analyses five months after transplantation, Mpp8-deficient recipients exhibited increased Dnmt3a-mutant representation within the Lin-Sca-1+c-Kit+ (LSK) and long-term HSC (LT-HSC) compartments. Strikingly, the absolute number of mutant LT-HSCs remained unchanged, whereas WT LT-HSC numbers were significantly reduced. Competitive transplantation using Vav-iCre;Tet2fl/+ BM produced the same pattern: WT LT-HSCs declined in Mpp8-deficient recipients, while Tet2-mutant LT-HSCs remained stable. These findings led us to hypothesize that chronic IFN-I promotes CH not through increased mutant expansion, but through selective erosion of the normal HSC pool.
To determine whether chronic IFN-I exposure ex vivo was sufficient to reproduce the selective loss of WT HSCs observed in vivo, we mixed WT and Dnmt3aR878H/+ LT-HSCs at a 2:1 ratio and cultured them on MS5 stromal cells for 11 days. IFN-α was added at 5 ng/mL on day 3 and replenished on days 5 and 8 (n=5-6 per group). Indeed, chronic IFN-α exposure increased the relative contribution of Dnmt3a-mutant LSK cells by reducing the WT LSK count without increasing the mutant LSK count. These ex vivo results recapitulate our in vivo findings that IFN-I promotes mutant clonal dominance by suppressing WT LSK fitness rather than directly stimulating mutant cell growth.
To examine the cellular mechanisms underlying this differential fitness, we assessed for changes to the cell-cycle and apoptosis. Under chronic IFN-I exposure, WT LSK cells accumulated in G1 and showed reduced progression into S/G2/M compared with Dnmt3a-mutant LSK cells. Although overall apoptosis was not increased, WT cells preferentially advanced toward late apoptotic states, while mutant cells remained predominantly in earlier apoptotic states. These results indicate that chronic IFN-I selectively compromises WT LSK cell cycle progression and survival while sparing Dnmt3a-mutant LSK cells.
To determine whether our competitive phenotype was driven by differences in IFN-I sensing, we first confirmed comparable expression of Ifnar1 between genotypes. We then performed reciprocal competition studies with IFN-α treatment using cells deficient in the interferon alpha receptor Ifnar1. Intriguingly, deletion of Ifnar1 in Dnmt3a-mutant HSCs did not eliminate their competitive advantage over WT HSCs. In contrast, Dnmt3a-mutant HSCs with intact Ifnar1 lost their advantage when competed against Ifnar1-deficient HSCs, identifying IFN-I sensing by WT HSCs as the critical competitive liability.
To dissect the intrinsic differences in IFN-I responsiveness, we performed RNA sequencing on the WT and Dnmt3a-mutant HSCs harvested from the Mpp8-sufficient or Mpp8-deficient recipient mice at the conclusion of the competitive transplants. WT HSCs mounted a strong interferon-stimulated transcriptional response in the Mpp8-deficient environment, whereas Dnmt3a-mutant HSCs were comparatively resistant. These results suggest that WT HSCs are more susceptible to IFN-I reprogramming than Dnmt3a-mutant HSCs.
Together, these findings establish chronic IFN-I as a cell-extrinsic driver of CH by eliciting a maladaptive response in WT HSCs that enables Dnmt3a- and Tet2-mutant clonal dominance. Our studies show that inflammatory stress can promote clonal evolution by selectively depleting normal HSCs without directly potentiating mutant fitness and may contribute to why mutant clones remain dormant until aging or inflammation permit their expansion.
DISCLOSURES
Qiongdi Zhang: No relevant conflicts of interest to declare.